KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other financing activities (2016 - 2025)

Historic Other financing activities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $57.0 million.

  • Amgen's Other financing activities rose 295000.0% to $57.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$52.0 million, marking a year-over-year increase of 5806.45%. This contributed to the annual value of -$52.0 million for FY2025, which is 5806.45% up from last year.
  • Amgen's Other financing activities amounted to $57.0 million in Q4 2025, which was up 295000.0% from $10.0 million recorded in Q3 2025.
  • Amgen's 5-year Other financing activities high stood at $57.0 million for Q4 2025, and its period low was -$92.0 million during Q2 2025.
  • Its 5-year average for Other financing activities is -$21.4 million, with a median of -$26.0 million in 2022.
  • Per our database at Business Quant, Amgen's Other financing activities crashed by 22142.86% in 2024 and then soared by 295000.0% in 2025.
  • Amgen's Other financing activities (Quarter) stood at $26.0 million in 2021, then plummeted by 61.54% to $10.0 million in 2022, then plummeted by 150.0% to -$5.0 million in 2023, then skyrocketed by 60.0% to -$2.0 million in 2024, then soared by 2950.0% to $57.0 million in 2025.
  • Its last three reported values are $57.0 million in Q4 2025, $10.0 million for Q3 2025, and -$92.0 million during Q2 2025.